Background An inflammatory myofibroblastic tumour (IMFT) is a rare mesenchymal
neoplasm characterised by anaplastic lymphoma kinase (ALK) gene rearrangements. We …

Soft Tissue Sarcomas (STS) is a heterogeneous and complex group of mesenchymal tumors
with an annual incidence of 50–60 new cases per million people and year, which means …

Abstract Background: Inflammatory myofibroblastic tumors (IMTs) are a rare subtype of
inflammatory pseudotumor frequently associated with rearrangement of the anaplastic …

Background Inflammatory myofibroblastic tumor (IMFT) is an uncommon neoplasm in
children. Methods Retrospective review from 1993 to 2014 of patients≤ 18 years of age with …

Systemic inflammatory myofibroblastic tumor is an exceedingly rare entity. A 45-year-old
Hispanic female presented with a 6-month history of left-sided thigh pain, low back pain, and …

An inflammatory myofibroblastic tumor (IMT) is a rare neoplasm with an unclear origin that
can arise anywhere on the body. It contains spindle cells (myofibroblasts) with different …

Background Inflammatory myofibroblastic tumours (IMTs) are rare sarcomas that were first
described in the lung. They are composed of myofibroblastic mesenchymal spindle cells …

Inflammatory myofibroblastic tumors (IMTs) are known to be associated with anaplastic
lymphoma kinase (ALK) gene rearrangements. Other molecular alterations such as ROS …

An inflammatory myofibroblastic tumor (IMT) is an immunohistochemically diverse entity
demonstrating neoplastic and nonneoplastic qualities. Although IMTs can arise in any area …

Retroperitoneal inflammatory myofibroblastic tumor (IMT) is a rare lesion of unknown
etiology. The management of IMT may be challenging due to its intermediate malignant …